Kingfisher Cooperative; LLC
Spokane, Washington 99202
0 studies enrolling now · 11 studies all time
What they study most
Alzheimer Disease, Alzheimer's Disease, Alzheimer's Disease Dementia, Cervical Dystonia, Cognitive Dysfunction, Early Alzheimer's Disease, Migraine, With or Without Aura, Mild Cognitive Impairment, Mild Cognitive Impairment Due to Alzheimer's Disease, Mild to Moderate Alzheimer's Disease
Studies at this site
- A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
- A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease — Running, not enrolling
- A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease — Running, not enrolling
- Study of the Oral Treatment MTR-601 in Cervical Dystonia — Paused
- Memory Improvement Through Nicotine Dosing (MIND) Study — Completed
- Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment — Completed
- A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease — Stopped early
- A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 — Stopped early
- A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities — Stopped early
- Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease — Completed
- Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention — Completed